Suboxone vs Vivitrol
Suboxone and Vivitrol both treat opioid use disorder. They are not interchangeable. Suboxone is an opioid. It binds to the same receptors that heroin or oxycodone bind to, just more slowly and with a ceiling. Vivitrol is the opposite. It is an opioid blocker that prevents anything from binding to those receptors at all. The choice between them is not a coin flip.
| Attribute | Suboxone (buprenorphine + naloxone) | Vivitrol (extended-release naltrexone) |
|---|---|---|
| FDA approval | Opioid use disorder | Opioid use disorder + alcohol use disorder |
| Mechanism | Partial opioid agonist | Full opioid antagonist (blocker) |
| Schedule | Schedule III controlled substance | Not a controlled substance |
| Dosing | Daily sublingual film or tablet | Once-monthly intramuscular injection |
| Withdrawal mitigation | Yes - relieves withdrawal directly | No - patient must already be opioid-free |
| Pre-treatment requirement | Mild to moderate withdrawal recommended | 7 to 10 days opioid-free minimum |
| Cravings reduction | Strong | Moderate (works through receptor blockade) |
| Overdose protection | Ceiling effect on respiratory depression | Blocks opioid effects entirely while active |
| Diversion potential | Yes - DEA Schedule III | No - no abuse potential |
| Prescriber requirements | Any DEA-registered prescriber post-MAT Act | Any licensed prescriber |
| Cost without insurance | ~$100 to $300 per month | ~$1,500 per month sticker |
| Medicaid coverage | Covered in all 50 states | Covered in all 50 states (J2315) |
| Daily commitment | Yes - take a film every day | No - one shot, four weeks of coverage |
| What happens if you use opioids | Reduced effect, partial blockade | No effect at all (full blockade) |
| What happens if you stop | Withdrawal returns within 24 to 48 hours | Receptors come back online over 7 to 14 days |
The mechanism difference, in plain terms
Imagine the opioid receptor as a parking spot. With Suboxone, buprenorphine pulls into the spot and stays there. It activates the receptor, but only partially, and it blocks heroin from parking there too. That is why Suboxone reduces cravings, prevents withdrawal, and makes most opioid use feel pointless on top of it.
Vivitrol does something different. Naltrexone walks into the parking spot and locks the gate. Nothing activates the receptor. No partial signal, no withdrawal relief, no "feel okay" effect. That is why patients have to be fully opioid-free before the first injection. If naltrexone hits the receptor while opioids are still circulating, it evicts them all at once. The result is precipitated withdrawal, which is unpleasant enough to land people in the ER.
Who Suboxone fits
Suboxone is the better starting point if any of these apply:
- You are still actively using opioids and cannot get to seven days clean without medical help
- You have a long history of high-dose opioid use, including methadone or fentanyl
- You have tried abstinence-based approaches and relapsed
- You want a medication that takes the edge off cravings continuously, not one that only blocks consequences
- You can be reliable about taking a daily film
The catch is that Suboxone is itself an opioid, and stopping it produces withdrawal. Patients sometimes describe feeling stuck on it. That is a real consideration but it is rarely a reason to avoid starting.
Who Vivitrol fits
Vivitrol is the better fit if:
- You have already detoxed (post-jail, post-residential, post-medical detox)
- You want a medication that is not itself an opioid
- You struggle with daily medication adherence and a monthly shot fits your life better
- You also have alcohol use disorder, since Vivitrol treats both at the same dose
- You have a job, a custody situation, or a probation requirement that makes drug-testing-positive-for-opioid-medications a problem
The catch with Vivitrol is the seven-to-ten day opioid-free window. Most people who relapse on Vivitrol relapse during that gap, before the first shot, or during the gap between shots if they fall behind on appointments.
What the evidence says
The X:BOT trial published in The Lancet in 2018 compared Vivitrol to Suboxone head-to-head over 24 weeks in 570 people with opioid use disorder. Once treatment started, both medications produced similar relapse rates. The catch was the induction phase: 28% of patients randomized to Vivitrol could not complete the detox required to start, compared to 6% on Suboxone. So among people who can get to the starting line, Vivitrol works about as well as Suboxone. Getting to the starting line is the hard part.
What about cost
Suboxone is the cheaper medication on cash price, roughly $100 to $300 per month for generic buprenorphine/naloxone films at a chain pharmacy. Vivitrol's sticker price is around $1,500 per shot. With insurance the gap narrows considerably. Both medications are covered by every state Medicaid program. Vivitrol's manufacturer Alkermes runs a copay assistance program that brings out-of-pocket cost down to $5 per shot for many commercial insurance plans. See Vivitrol cost without insurance for the full breakdown.
The honest take
Most patients with active, untreated opioid use disorder should start on Suboxone. It is easier to begin, it works during the chaotic early weeks when relapse risk is highest, and it gets people stable. Vivitrol shines as a maintenance option after stabilization, especially for patients leaving residential treatment or jail, or patients with co-occurring alcohol use disorder. Treating the two as competitors misreads what each is good for.